IFNG and renal fibrosis: Here we tested the hypothesis that compared to the previously tested non-targeted full-length IFNγ [12], specific delivery of Fibroferon to PDGFβR-overexpressing interstitial myofibroblasts attenuates renal fibrosis and reduces inflammation-mediated side-effects in the mouse UUO model.